Maximum quantity allowed is 999
Please select the quantity
CAS RN: 72956-09-3 | Product Number: C2260
Carvedilol
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 5G |
$135.00
|
10 | 16 | It can be shipped in about 2 weeks after ordering | |
| 25G |
$476.00
|
11 | 20 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | C2260 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__4H__2__6N__2O__4 = 406.48 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 72956-09-3 |
| Reaxys Registry Number | 1514452 |
| PubChem Substance ID | 87560280 |
| SDBS (AIST Spectral DB) | 52170 |
| Merck Index (14) | 1873 |
| MDL Number | MFCD00864692 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 115.0 to 119.0 °C |
Properties (reference)
| Melting Point | 117 °C |
| Solubility in water | Insoluble |
| Solubility (soluble in) | Methanol |
| Solubility (slightly sol. in) | Ether, Ethanol |
GHS
| Pictogram |
|
| Hazard Statements | H411 : Toxic to aquatic life with long lasting effects. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P391 : Collect spillage. |
Related Laws:
| RTECS# | UA8670000 |
Transport Information:
| UN Number | UN3077 |
| Class | 9 |
| Packing Group | III |
| H.S.code* | 2933.99-000 |
Application
Carvedilol: A Nonselective β-Adrenoceptor Antagonist with α1-Receptor Antagonistic Activity
Carvedilol is a nonselective β1 and β2-adrenoceptor antagonist1) with α1-receptor antagonistic activity.2) The ratio of β1:β2 adrenergic activity is 7:1,1) and the ratio of α:β adrenergic activity is 1:8.3) Carvedilol is a racemic mixture, and the β-adrenoreceptor blocking activity is present in the S-(-)-enantiomer and α1-adrenergic blocking activity is present in both R-(+) and S-(-)-enantiomers at equal potency.4) Carvedilol also has antioxidant and antiproliferative effects.5) Furthermore, carvedilol is able to stimulate β-arrestin-mediated signaling.6) (The product is for research purpose only.)
References
- 1)Pharmacological Profile of Carvedilol as a β-Blocking Agent with Vasodilating and Hypotensive Properties.
- 2)Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation
- 3)Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine
- 4)Clinical pharmacokinetics and pharmacodynamics of carvedilol (a review)
- 5)Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger (a review)
- 6)A unique mechanism of β-blocker action: carvedilol stimulates β-arrestin signaling
PubMed Literature
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.